University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Faculty Publications in Food Science and
Technology

Food Science and Technology Department

2014

Safety assessment of the calcium-binding protein,
apoaequorin, expressed by Escherichia coli
Daniel L. Moran
Quincy Bioscience LLC, dmoran@quincybioscience.com

Afua O. Tetteh
University of Nebraska–Lincoln

Richard E. Goodman
University of Nebraska-Lincoln, rgoodman2@unl.edu

Mark Y. Underwood
Quincy Bioscience LLC

Follow this and additional works at: http://digitalcommons.unl.edu/foodsciefacpub
Part of the Food Science Commons
Moran, Daniel L.; Tetteh, Afua O.; Goodman, Richard E.; and Underwood, Mark Y., "Safety assessment of the calcium-binding
protein, apoaequorin, expressed by Escherichia coli" (2014). Faculty Publications in Food Science and Technology. 154.
http://digitalcommons.unl.edu/foodsciefacpub/154

This Article is brought to you for free and open access by the Food Science and Technology Department at DigitalCommons@University of Nebraska Lincoln. It has been accepted for inclusion in Faculty Publications in Food Science and Technology by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.

Published in Regulatory Toxicology and Pharmacology 69:2 (July 2014), pp. 243–249; doi: 10.1016/j.yrtph.2014.04.004
Copyright © 2014 Elsevier Inc. Used by permission.
Submitted February 13, 2014; published online April 24, 2014.
digitalcommons.unl.edu
digitalcommons.unl.edu

Safety assessment of the calcium-binding protein,
apoaequorin, expressed by Escherichia coli
Daniel L. Moran,1 Afua O. Tetteh,2 Richard E. Goodman,2 and Mark Y. Underwood1
1 Quincy Bioscience LLC, Suite 200, 301 South Westfield Road, Madison, WI 53717, USA
2 Food Allergy Research and Resource Program, 351 Food Industry Complex, University of Nebraska–Lincoln, Lincoln, NE 68583-0919, USA
Corresponding author — D.L. Moran, fax 608-833-2714; email dmoran@quincybioscience.com

Abstract
Calcium-binding proteins are ubiquitous modulators of cellular activity and function. Cells possess numerous calcium-binding proteins that regulate calcium concentration in the cytosol by buffering excess free calcium ion. Disturbances in intracellular calcium homeostasis are at the heart of many age-related conditions making these proteins targets for therapeutic intervention. A calcium-binding protein, apoaequorin, has shown potential utility in a broad spectrum of applications for
human health and well-being. Large-scale recombinant production of the protein has been successful; enabling further research and development and commercialization efforts. Previous work reported a 90-day subchronic toxicity test that demonstrated this protein has no toxicity by oral exposure in Sprague–Dawley rodents. The current study assesses the allergenic
potential of the purified protein using bioinformatic analysis and simulated gastric digestion. The results from the bioinformatics searches with the apoaequorin sequence show the protein is not a known allergen and not likely to cross-react with
known allergens. Apoaequorin is easily digested by pepsin, a characteristic commonly exhibited by many non-allergenic dietary proteins. From these data, there is no added concern of safety due to unusual stability of the protein by ingestion.
Keywords: Safety assessment, Apoaequorin, Allergenicity, Bioinformatic, Calcium-binding protein

1. Introduction

particularly, brain cell physiology (Grienberger and Konnerth,
2012 and Kendall and Badminton, 1998). Some calcium-binding proteins coordinate the role of the calcium ion in the cell;
maintaining calcium homeostasis within finely tuned concentration limits to avoid toxicity while preserving calcium’s influence
on cell physiology.
Because of its unique commercial value, a large-scale manufacturing process has been developed to produce kilogram quantities of this protein for use in a number of applications pertinent to
human health and well-being. The potential increased exposure of
human and animal populations to this protein required a toxicological and allergenic analysis from regulatory agencies and industrial best-practice standards. An extensive 90-day subchronic toxicology study was performed in Sprague–Dawley rats to test the
oral route of delivery of the purified protein (Moran et al., 2013).
There were no clinical pathology or histopathological changes in
the animals receiving the protein and any changes of note were
typical of those historically observed changes in the age and strain
of rats used in the study. A No Observed-Adverse-Effect Level
(NOAEL) for apoaequorin was determined at 2000× (expected human exposure) and an ADI safety margin of 666.7 mg/kg bwt/day
was established, which was the highest dose tested.

The calcium-binding protein apoaequorin, endogenous to the
luminescent jellyfish Aequorea victoria, has been used for over
40 years as a research molecule in studies of intracellular physiology of the calcium ion. This small protein (22.3 kDa) possesses
three calcium-binding sites of the EF-hand motif and belongs to
the superfamily of calcium-binding proteins that facilitate signal transduction, gene transcription, enzyme activation, intracellular calcium buffering and in the case of conjugated form of
apoaequorin, aequorin, and related proteins, bioluminescence
(Deng et al., 2004, Heizmann, 1992, Deng et al., 2005 and Yáñez
et al., 2012). When the apo-form of the protein is conjugated to
its prosthetic group, coelenterazine, the resulting molecule, aequorin, luminesces upon binding the calcium ion in vivo or in vitro (Kendall and Badminton, 1998). Properly stimulated, cells containing aequorin release light showing where, when and how
much free, cytosolic calcium ion is released from internal stores
or across the cell membrane in response to stimuli (Snowdowne
et al., 1984). This photoprotein has been used for in vitro and in
vivo studies as an indicator molecule for understanding calcium’s role in signal transduction, metabolism, development, and
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The current study continues the risk assessment of the protein through bioinformatic and simulated gastric digestion tests
to evaluate the potential allergenicity of this protein. Characterization of the expressed protein included N-terminal sequencing,
molecular weight determination, and luminescent activity, which
verified the identity and functionality of the protein. With the expected post-translational processing and the fidelity of the genetic expression construction confirmed, an allergenic risk assessment was performed. This included a protein sequencing
analysis in an exhaustive bioinformatic assessment against allergen databases and an in vitro simulated gastric digestion of
the protein. These approaches have proven invaluable as tools
in assessing the potential allergenicity of genetically engineered
proteins since they consider the primary amino acid sequence
of known allergenic proteins that could pose a risk of allergy to
those sensitized by other exposure and in evaluating the likelihood the novel protein might pose a high risk of sensitization
or elicitation upon ingestion. Although the tests cannot prove an
absence of risk of allergy, they have been deemed highly predictive of a protein’s allergenic potential.
In vitro digestion in pepsin was performed to determine the
level of resistance to protease cleavage under optimum pH conditions. Investigation of proteins that have been tested in this
way suggest a strong positive predictive value that food allergens causing systemic reactions are relatively stable in the assay, while non-allergenic food proteins are typically digested
relatively quickly (Bannon et al., 2002). Astwood et al. (1996) published the first use of in vitro pepsin digestion as an assay showing that many food allergens or protein fragments were resistant
to digestion. Thomas et al. (2004) published a method standardizing the pH, purity of the protease, ratio of pepsin to test article,
and purity of the test protein. We (Ofori-Anti et al., 2008) added
an objective measure of the degree of digestion to improve the
evaluation for assessing digestibility. However, although a correlation exists between allergenicity of dietary proteins and pepsin resistance (Astwood et al., 1996) some unstable allergens
may be protected in the food matrix of the gut in vivo (Polovic et
al., 2007). Since no single determinant has been found to be full
proof for predicting allergenicity, international consensus has established a weight-of-evidence approach in assessing allergenic
potential of new proteins (Codex, 2003).
2. Method and materials
2.1. Strain development
A synthetic gene for the protein sequence P02592 (UniProtKB/
Swiss-Prot) was codon-optimized for expression in a prokaryotic
cell line. The synthetic gene (Life Technologies) was subcloned
into an expression cassette following standard molecular protocols for site-specific integration into the host strain, Escherichia coli
BL21(DE3), and targeted secretion to the fermentation medium.
Genomic insertion of the gene was performed by the homologous recombination method of Hamilton et al. (1989) with variations needed to target a non-essential operon of the host strain.
Clones carrying only the expression cassette minus vector DNA
were isolated using PCR for both the gene of interest and the antibiotic resistance gene. Isolated clones were verified by Southern
blot analysis using radiolabeled probes of the antibiotic and gene
of interest sequences (data not shown). A single clone was developed for industrial production of the protein and was named QB6.
The fidelity of the genomic insertion sequence was verified
by DNA sequencing through PCR amplification using the primer
pairs specific to the coding region; CAG TAT AGC GTC AAA CTG
as the forward primer and TGG TGC TCG ACT TAT TAC for the reverse primer. A single band of the PCR product was visualized

by agarose gel electrophoresis. The band was excised from the
gel and was sequenced analysis in both directions (ACGT, Inc.,
Wheeling, IL).
2.2. Protein production and purification
Fermentation of the strain was performed by large-scale production processes and successfully produced multi-gram quantities of
the secreted protein using lactose induction in a proprietary medium formulation. Clarification of the resulting fermentation broth
by tangential flow filtration was followed by large-scale ion exchange chromatography. This resulted in a solution of the protein
that was 90% pure. Acid precipitation with 10% acetic acid to a pH
of 4.2 was followed by centrifugation at 2500g for 30 min. The supernatant was poured off, which aided in the removal of UV absorbing contaminants, leaving concentrated protein as the pellet. Resuspension of the protein (25 mM TRIS, 25 mM NaCl and
1 mM EDTA, pH 8.5) followed by gel filtration chromatography removed residual salts and contaminants. Pooled fractions from gel
filtration were concentrated through tangential flow filtration using membranes of a nominal molecular weight cutoff of 5 kDa to
obtain an approximate concentration of 20 mg/mL solution as determined by absorbance at 280 nm (A280) and a theoretical extinction coefficient for the apoprotein of 2.0. The protein was sterile filtered and kept frozen at −20 °C in buffer (25 mM TRIS, and
25 mM NaCl, pH 7.6), until use.
2.3. Protein characterization
N-terminal sequence of the first 30 amino acids of the recombinantly expressed apoaequorin was determined from samples purified from culture medium by SDS–PAGE and electroblotted onto a
PVDF membrane. The protein bands were visualized by Ponseau S
staining and N-terminal sequencing was completed at the Medical
College of Wisconsin Protein and Nucleic Acid Facility.
The protein was further characterized by SDS PAGE (Novex BisTris 4–12% gradient gels following the manufacturer’s instructions
– Life Technologies). The gel was stained with a commercial preparation of coomassie brilliant blue solution (Thermo Fisher Imperial
Protein Stain) and destained overnight in distilled water. The destained gels were visualized in a Kodak Gel Logic 440 Image Station under white light transillumination. The image was captured
and purity was estimated by densitometric analysis of the stained
gel. This estimate was used in digestion studies of the protein.
Enzymatic activity of the protein was determined by regenerating the holoprotein, aequorin, and demonstrating calcium-binding activity through the chemiluminescence of the protein. Methods for the regeneration, luminescent activity, and measurements
of photons followed Shimomura (1991) with minor modifications.
Briefly, the assay was miniaturized for use in white, 96-well microtiter plate format to measure luminescence. Bioluminescence was
measured on a Biotek luminometer plate reader controlled by the
KC4 software (Biotek). Samples were discharged to produce blue
light (462 nm) by the addition of 300 μL of assay buffer (20 mM
calcium acetate in 10 mM TRIS, pH 7.6). Photons were collected
over a three-second time period and maximum luminosities were
averaged by the software for each dilution of each sample. The average relative luminous units were calculated for each sample. The
results from eight dilutions were averaged for each sample and
these data were validated by comparative analysis against the protein’s kinetic accumulation during fermentation.
2.4. Allergenicity testing: Sequence search in silico
Potential allergy and cross-reactivity risk assessment was performed using methods typically used for food-safety evaluation as
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prescribed by the Codex Alimentarius Guidelines (2003). The bioinformatics study was designed to compare the protein sequence
of apoaequorin with those of known allergens in 2010 with version 10 of the AllergenOnline.org database (AOL v10) maintained
by the Food Allergy Research and Resource Program (FARRP) at
the University of Nebraska. This was repeated with version 13
of AllergenOnline.org on 5 December 2013 along with BLASTP
searches of NCBI Protein database to evaluate possible matches to
newly discovered allergens. The purpose of the search was to determine whether the protein could be identified as a known allergen (~95–100% match to an allergen listed in AllergenOnline.org),
or was sufficiently similar to a known allergen (>35% identity over
any segment of 80 amino acids) to suspect potential allergic crossreactivity. The first search was performed using the FASTA3 algorithm (Pearson, 2000) with the default scoring matrix (BLOSUM 50)
to evaluate overall alignment of each query sequence compared
to all sequences in AllergenOnline, looking for matches of low Escore values (<1e-7) and greater than 50% identity as likely significant scores suggesting potential cross-reactivity.
Additionally, an 80-amino acid sliding window identity search
was performed that systematically tests all possible 80-amino acid
segments of apoaequorin with >35% identity to any known or putative allergen listed in the AOL database, using the same FASTA3
algorithm. Significant matches identified by either search would
suggest a need to perform human serum testing using sera from
specifically allergic donors to evaluate for potential IgE cross-reactivity (Codex, 2003).
Additional information considered in this study included a
search of the protein sequence for any eight contiguous amino acid
matches (8mer) to any known allergen in AOL. This step is required
by some international regulatory agencies however, it has not been
demonstrated to have a substantial predictive value for allergenicity.
This step was included to meet our regulatory purposes.
The protein sequence was also searched against the non-redundant NCBI dataset using BLASTP with default values for
BLOSUM 62 to evaluate homologs of the query protein to understand protein function and further screen for potential safety issues. This protein is in the family of Ca+2 binding proteins and is
most closely related to similar proteins from other hydrozoans of
the phylum Cnidaria with E-scores smaller than 10−40 and identities of >60% over the full-length. Additionally, a BLASTP search
using the keyword limit of “allerg*” to any “keyword” allergen sequence in NCBI with an E-score smaller than 10−3 or a sequence
homology of >35% identity was performed.
References in the PubMed database were also searched using
the organism name (A. victoria) as well as family name (Aequoreidae) and the keyword “allerg*” to learn whether there is information to indicate whether the source organism is a common cause
of allergy.
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study. The assay was performed at 37 °C and samples removed at
specific times and the activity of pepsin quenched by neutralization with carbonate buffer and Laemmli loading buffer. Samples
were then heated to more than 70 °C for 5 min and frozen until
analyzed by SDS–PAGE. The timed digestion samples were separated by SDS–PAGE (Novex 10–20% tris–glycine gels following the
manufacturer’s instructions – Life Technologies) fixed, and stained
with coomassie or colloidal blue to evaluate the extent of digestion. All samples on each gel were from a single digestion experiment. The samples were heat to 95 °C, cooled and 10 μL each were
loaded per well (1.47 μg protein per well). Bio-Rad Precision Plus
molecular weight marker proteins were loaded in one outer well,
Invitrogen Sharp Standards marker LC5800 was loaded in the opposite outer well. Stained gels were visualized in a Kodak Gel Logic
440 Image Station under white light transillumination.
Based on the purity of apoaequorin by densitometry of SDS
PAGE, the limit of detection was estimated using serial dilutions of
samples of purified test protein. Undigested samples representing
100% and 10% of the undigested protein were then included in
the analytical digestion gels as reference standards.
3. Results and discussion
3.1. Verification of expression genetics
Verification of the integration of the expression construct into the
host chromosome was determined by PCR and DNA sequencing
of the amplified gene. The translated amino acid sequence was
identical to the full-length, naturally occurring protein found in the
jellyfish.
Following fermentation, the protein accumulated in the medium of the broth and samples from time points during fermentation were used for protein activity assays (Figure 1) and SDS PAGE
analysis (Figure 2). Protein accumulation and luminescent activity agreed well for each time point. The SDS–PAGE demonstrated
complete N-terminal cleavage of the signal peptide sequence, successful secretion of the protein into the medium, and confirmed
the correct molecular weight of 22.3 kDa. The luminescent activity of the protein increased in accordance with the accumulation of
the band density on the SDS–PAGE indicating production and secretion of a properly folded and fully functional protein into the
medium. Apoaequorin was purified to homogeneity and concentrated to 20 mg/mL.

2.5. Simulated gastric digestion
The pepsin stability assay is one study in a “weight of evidence
approach” intended to assess the potential allergenicity of genetically modified crops (Codex, 2003). The assay described by Astwood et al. (1996) was refined further; adding an objective measurement of the extent of digestion as described by Ofori-Anti et
al. (2008). The assay was performed under standard conditions of
10 units of pepsin activity per microgram of test protein using a
high purity form of pepsin from Worthington Biochemical, Corp.,
The mass ratio was approximately 3.6 mg pepsin per mg of test
protein and other quality control measures as recommended by
Ofori-Anti et al. (2008) were followed.
The original assay described by Astwood et al. (1996) recommends performing the digestion at pH 1.2. However, the FAO/
WHO (2001) recommends using two pH conditions (pH 1.2 and pH
2.0). Two independent assays were conducted at each pH in this

Figure 1. Kinetic results of the fermentation of the QB6 clone showing luminous activity of the charged apoaequorin (aequorin) as it increased as protein accumulated in the broth of the medium. Arrows
indicate the time points for lactose induction of the gene. MMRLU/s/
μL = maximum relative luminous units in millions of photons per second per μL of sample.
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Figure 2. SDS PAGE and coomassie blue staining of samples from selected fermentation time points. Lane M, protein marker, Lane 1 broth
before inoculation, Lane 2 at inoculation, Lane 3 at 0.2 h fermentation,
Lane 4 at 3 h, Lane 5 at 6 h, Lane 6 at 8 h, Lane 7 at 22 h.

The first 30 residues of the protein were determined to be correct through N-terminal protein sequence analysis (Figure 3). This
is as expected from the predicted DNA sequence of the expression
cassette. The protein was produced and processed correctly, creating the same protein as found endogenously in the jellyfish.
3.2. In silico allergen sequence alignments
The full-length sequence of apoaequorin (196 amino acids), (UniProtKB/Swiss-Prot: P02592.1) was used to search the AllergenOnline.org database. No native signal peptide has been identified for
this protein from A. victoria, according to Hamamoto et al. (2003)
as a direct NCBI entry (2003). Results of the FASTA3 search of the
apoaequorin against the AllergenOnline.org (version 10 and version 13) did not identify any significant alignment with any allergen.
Scoring results for the four best scoring alignments demonstrate
no significant matches with any allergen (Table 1). The highest scoring alignments were to a calcium-binding protein of olive pollen
(Olea europaea) and a number of fish parvalbumin calcium-binding
proteins. While the E-scores and identities suggest possible evolutionary homology, the alignments represent less than one-third of
the length of apoaequorin and the similarities are not sufficiently
high to suspect shared antibody binding cross-reactivity.

Figure 3. Amino acid sequence of apoaequorin (P02592). The encoded
protein is 196 amino acids in length based on translation of the DNA
sequence. The first 30 amino acids (underlined) of the expressed and
purified protein were confirmed by LC–MSMS as described in the text.

Figure 4. Colloidal blue stained SDS–PAGE gel apoaequorin for limit of
detection. Samples of a dilution series of the apoaequorin was loaded
and separated by SDS–PAGE using a 10 → 20% polyacrylamide tris–
glycine gradient gel. A Bio-Rad Precision Plus marker protein was used
to estimate MW. Proteins were detected by staining with colloidal brilliant blue G stain.
Lane

Description

Quantity of protein
loaded/well

1
2
3
4
5
M
6
7
8
9
10
11
12
13
14

Apoaequorin (300%)
Apoaequorin (200%)
Apoaequorin (175%)
Apoaequorin (150%)
Apoaequorin (125%)
Bio-Rad Precision Plus MW Marker
Apoaequorin (100%)
Apoaequorin (80%)
Apoaequorin (60%)
Apoaequorin (50%)
Apoaequorin (40%)
Apoaequorin (20%)
Apoaequorin (10%)
Apoaequorin (5%)
Apoaequorin (2.5%)

4.41 μg
2.94 μg
2.57 μg
2.21 μg
1.84 μg
na
1.47 μg
1.18 μg
0.88 μg
0.74 μg
0.59 μg
0.29 μg
0.15 μg
0.07 μg
0.04 μg

The identity results from FASTA3 alignments using the sliding
window of 80-amino acid algorithm did not identify any alignments of >35% identity to any entry in the AllergenOnline.org
database (version 10 or 13). Furthermore, there were no identity
matches of eight-contiguous amino acids between apoaequorin
sequence and any entry in the AllergenOnline.org database.
The full-length apoaequorin was also compared to sequences
in NCBI-Entrez using a keyword limit of “allerg*” on 20 June
2010 and again on 5 December 2013 (Table 2). No alignments
were identified with E scores below “1 × e 10−7”, or with identity
matches of greater than 35% over any alignment of more than 80
amino acids. These bioinformatics results did not identify any significant alignments to any known allergens. In contrast, when no
keyword limit was used, many high-scoring identity matches were
found to other photo-proteins as homologs of apoaequorin from
other jellyfish relatives.
A PubMed search was conducted to identify any publications
that suggest the species (A. victoria) or other members of related
taxa are known to be significant inducers of allergy. Keyword search
terms included “Aequorea AND allergen/allergy”, “Aequoreidae AND
allergen/allergy” (family) and “Cnidaria AND allergen/allergy” (phylum). The search was conducted on 19 June 2010. The only two
publications identified by species search reports a study of protein
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Table 1. Overall FASTA3 search of AllergenOnline version 10.0 with APQ. Four highest scoring alignments of known and putative allergens in AllergenOnline are shown to compare apoaequorin with version 10 of the AllergenOnline.org database using FASTA3.
Sequence GI#
3337403
131112
77799800
14531018

Organism

Description

Olea europaea olive
Gadus callarias codfish
Trachurus japonicus Japanese mackerel
Theragra chalcogramma Alaska pollock

Ca+2

Length

E score

% Identity

aa alignment

84
113
107
109

0.088
0.24
0.37
0.68

33.3
35.7
34.5
32.7

51
56
55
55

binding protein
Parvalbumin
Parvalbumin
Parvalbumin

Table 2. BLASTP of NCBI Entrez “allerg*” with APQ. The scoring alignments of ten best scoring matches with E scores below 10, to putative allergens in the NCBI Entrez database on 20 June, 2010, were compared to the full-length sequence of apoaequorin, using BLASTP.
Sequence GI#

Organism

Description

3I7C_A
3I79_A
ABF18354.1
XP_751821.2
BAB86193.1
AAX77686.1
XP_751821.2
O81092.1
ADD19708.1
AAT92161.1

Toxoplasma gondii amoeba
Toxoplasma gondii amoeba
Aedes aegypti mosquito
Aspergillus fumigates fungus
Oryza sativa rice
Ambroxia artemisiifoliashort ragweed
Aspergillus fumigatus fungi
Olea europaea rice
Glossina morsitans fly
Ixodes pacificus tick

Ca+2 dependent protein kinase
Ca+2 dependent protein kinase
Calmodulin
Ca+2 dependent mitochondrial carrier protein
Putative pollen allergen Jun 0 4
Ca+2 bindin protein
Calmodulin
Polcalcin
Calmodulin
Myosin light chain

stability of heterologously expressed proteins using the Turnip Mosaic Virus (Chen et al., 2007) and Golgi trafficking of expressed proteins (Luo et al., 2006). Both use the green fluorescent protein of this
species as a marker, with no indication the protein is an allergen. No
publications were found using the family name “Aequoridae” with
“allergen: or “allergy.” Seventy-one publications were identified using the terms “Cnidaria AND allergy”. Most of the 71 papers describe allergic reactions to contact with a variety of jellyfish, corals,
and anemones or treatment of allergic reactions. Only one paper reported identification of the allergenic protein and that (Onizuka et
al., 2001) was identified by search through the three publications
identified by “Cnidaria AND allergen”, describing allergy to an allergenic protein, of the coral Dendronephthya nipponica.
3.3. In vitro digestion assay
This study evaluated the stability of apoaequorin in two replicate
assays using pepsin at both pH 1.2 and 2.0. A number of control
steps were performed to ensure study validity including verifying that the activity of the pepsin at pH 1.2 and 2.0 was within
the target activity range of 2750 units per mg of solid pepsin, plus
or minus 23% on each day of assay. Preliminary SDS–PAGE results
demonstrated that the apoaequorin was as expected in molecular weight and that the sensitivity of the stained gels and imaging
system were sufficient to detect the protein from digestion samples below 10% of the starting material (Figure 4). Specific net intensity values from the Gel Logic 440 image station were plotted in
a regression (Figure 5) with apparent good fit (r2 = 0.91). Based on
these data, the limit of detection was approximately 2.5% (0.04 μg)
of apoaequorin 100% loading (1.47 μg) used in the digestion samples. This level of sensitivity was clearly sufficient to detect 10% residual protein in the digest.
The certified activity of the lot of pepsin from Worthington Biochemical used in this study was 2750 units per mg of solid. The activity was also verified in the laboratory and was within our quality
control range. Representative stained gels of replicated digestion
experiments at pH 1.2 and pH 2.0 demonstrated that apoaequorin
is stable in acid alone (pH 1.2 or 2) for 60 min (lane 3). It was however, digested by 0.5 min in pepsin at acidic pH (lane 5) to the extent that it was less intense than the 10% apoaequorin control in

Length
484
484
149
585
185
160
149
84
149
174

E score % Identity aa alignment
0.002
0.003
0.01
0.037
0.06
0.069
0.18
0.22
0.34
0.39

27%
27%
24%
32%
31%
24%
20%
33%
22%
22%

90
90
153
59
73
157
158
51
150
168

quenched pepsin (Figure 6). Thus, the estimated time for 90% digestion was less than 30 s in all digestion experiments. Apoaequorin is therefore considered a rapidly digested protein.
4. Discussion
None of the results from the bioinformatics searches with the
apoaequorin sequence met the criteria that suggest the protein is
an allergen or poses a risk of allergenic cross-reactivity or would require further testing to evaluate potential risks. In addition, the general bioinformatics search of NCBI without a keyword limit demonstrated the protein is highly conserved across a broad range of taxa
within jellyfish with no obvious published indication of allergy associated with homologous proteins. Furthermore, searches of published literature failed to identify a report, demonstrating allergy to
A. victoria or other family members, but did identify one publication
regarding a single protein in a different group within the phylum
Cnidaria. A number of publications reported allergic or allergic-like
reactions to various jellyfish, corals, and anemones in this phylum,
but a paucity of information regarding the proteins implicated in
sensitization. These results suggest that the entire phylum is not a
significant cause of allergic reactions in humans.
The proteins that had regions of limited homology that did
arise in the sequence search of the NCBI protein database were
calcium-binding proteins and the alignments were in the region
of calcium binding. This is not surprising since the signature motif
for calcium-binding proteins is the EF-hand conformation that is
created by the protein’s helix-loop-helix secondary structure. However, it is not the primary sequence of the motif that is conserved
but similar residues (size and charge) that is characteristic of calcium-binding proteins.
Epitope mapping of peptide fragments of calcium-binding proteins of known allergenicity has implicated some residues of an
EF-hand motif as in the case of parvalbumin; however, the role of
these residues in the tertiary conformation of the motif and dependence on the presence or absence of bound calcium ion
(Perez-Gordo et al., 2013) makes extrapolation to globular proteins speculative. In any case, poor sequence alignment of the
apoaequorin EF-hand domains with the calcium-binding domains
of other proteins does not support the allergenic potential for
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Figure 5. Densitometer readings for the limit of detection of apoaequorin from the colloidal blue stained SDS–PAGE gel (see Figure 1). The Kodak
Gel Logic 440 with 1D software was used to make the estimation of stainable protein band. Excel was used to calculate the regression and equivalent protein content based on 100% being equal to 1.47 μg per lane. Target apoaequorin amount per lane is 1.47 μg. (A) Lanes 1–14 represent
30%, 200%, 175%, 150%, 125%, 100%, 80%, 60%, 50%, 40%, 20%, 10%, 5%, 2.5% of the target apoaequorin amount, respectively. (B) Densitometer
readings for the limit of detection of apoaequorin from the colloidal blue stained SDS–PAGE gel (see sub-Figure A). The Kodak Gel Logic 440 with
1D software was used to make the estimation of stainable protein band. Excel was used to calculate the regression and equivalent protein content
based on 100% being equal to 1.47 μg per lane.

Figure 6. Detection of apoaequorin at pH 1.2 (sub-figure A) and pH 2.0 (sub-figure B) with 10,000 pepsin activity units per mg apoaequorin. Digestion products were separated in SDS–PAGE 10–20% gels under reducing conditions. Sample lanes: (m), BioRad# 161-0374 and Invitrogen LC5800
marker proteins; 1.47 mg of undigested apoaequorin without pepsin (A) at time 0; (B) at time 60 min; (C–J) apoaequorin plus pepsin at times 0,
0.5, 2, 5, 10, 20, 30, and 60 min of digestion (respectively); K, pepsin alone at time 0; N, pepsin alone at time 60 min; L, undigested apoaequorin
0.147 μg (10%) at time 0.
Lane

Description

Incubation time

M
A
B
C
D
E
F
G
H
I
J
K
L
N
M

Molecular weight marker Bio-Rad
Apoaequorin control without pepsin (P0)
Apoaequorin control without pepsin (P60)
Apoaequorin in SGF, (DC)
Apoaequorin in SGF, (D0.5)
Apoaequorin in SGF, (D2)
Apoaequorin in SGF, (D5)
Apoaequorin in SGF, (D10)
Apoaequorin in SGF, (D20)
Apoaequorin in SGF, (D30)
Apoaequorin in SGF, (D60)
Experimental control pepsin (E0)
Experimental control pepsin (E60)
10% apoaequorin with quenched pepsin (dC)
Molecular weight marker Invitrogen

na
0
60
0
0.5
2
5
10
20
30
60
0
60
0
na

the protein. Additionally, the ability to predict allergenic epitopes
based on predicted three-dimensional modeling or other structural prediction tools has not been demonstrated through validation to be highly predicted and is thus not recognized as a risk assessment tool for food safety (Goodman and Tetteh, 2011). Instead
primary sequence comparisons using FASTA (Pearson, 2000) or
BLASTP (Pearson, 1995) have been demonstrated to be useful for
identifying proteins that are sufficiently similar in primary structure

min
min
min
min
min
min
min
min
min
min
min
min
min

to suspect possible shared IgE binding that might be clinically relevant for allergic consumers (Goodman et al., 2008). Thus, the criteria of the Codex Alimentarius Commission (2003) were followed
in the bioinformatics analysis used to evaluate potential cross-reactivity. The results did not identify any significant matches to any
allergenic protein. This demonstrates that apoaequorin is not expected to have any significant risk of allergic cross-reactivity for
those who are allergic to known allergens. In fact, based on these
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results, it would not be possible to identify allergic individuals who
would be at a heightened risk by exposure to this protein.
In vitro digestion models are used widely to assess the digestibility of ingested substances. Resistance to digestion is typical of
allergenic proteins. Based on this study, the rapid digestion characteristics of apoaequorin were similar to those of common nonallergenic dietary proteins.
From these data, there is no added concern of safety due to
gastrointestinal stability of the protein.
Disclosures — Dr. R. Goodman reports grants from Quincy Bioscience LLC, during the conduct of the study. Dr. M.Y. Underwood has
a patent US No. 7,671,015 issued, a patent US Appl. 12/694,427
pending, and a patent US Appl. 12/672,463 pending. Dr. A. Tetteh
has nothing to disclose.
Appendix A. Supplementary data
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